These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16317288

  • 1. Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells.
    Santen RJ, Lynch AR, Neal LR, McPherson RA, Yue W.
    Anticancer Drugs; 2006 Jan; 17(1):33-40. PubMed ID: 16317288
    [Abstract] [Full Text] [Related]

  • 2. Improving Therapeutic Potential of Farnesylthiosalicylic Acid: Tumor Specific Delivery via Conjugation with Heptamethine Cyanine Dye.
    Guan Y, Zhang Y, Xiao L, Li J, Wang JP, Chordia MD, Liu ZQ, Chung LW, Yue W, Pan D.
    Mol Pharm; 2017 Jan 03; 14(1):1-13. PubMed ID: 26992462
    [Abstract] [Full Text] [Related]

  • 3. The inhibition of human mesangial cell proliferation by S-trans, trans-farnesylthiosalicylic acid.
    Khwaja A, Sharpe CC, Noor M, Kloog Y, Hendry BM.
    Kidney Int; 2005 Aug 03; 68(2):474-86. PubMed ID: 16014024
    [Abstract] [Full Text] [Related]

  • 4. Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells.
    Yue W, Wang J, Li Y, Fan P, Santen RJ.
    Int J Cancer; 2005 Dec 10; 117(5):746-54. PubMed ID: 15957161
    [Abstract] [Full Text] [Related]

  • 5. Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells.
    Erlich S, Tal-Or P, Liebling R, Blum R, Karunagaran D, Kloog Y, Pinkas-Kramarski R.
    Biochem Pharmacol; 2006 Aug 14; 72(4):427-36. PubMed ID: 16780807
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B, Starinsky S, Friedman E, Stein R, Kloog Y.
    Clin Cancer Res; 2006 Sep 15; 12(18):5533-42. PubMed ID: 17000690
    [Abstract] [Full Text] [Related]

  • 11. The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance.
    Gana-Weisz M, Halaschek-Wiener J, Jansen B, Elad G, Haklai R, Kloog Y.
    Clin Cancer Res; 2002 Feb 15; 8(2):555-65. PubMed ID: 11839677
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hybrid molecule from Farnesylthiosalicylic acid-diamine and phenylpropenoic acid as Ras-related signaling inhibitor with potent antitumor activities.
    Ling Y, Wang Z, Wang X, Li X, Wang X, Zhang W, Dai H, Chen L, Zhang Y.
    Chem Biol Drug Des; 2015 Feb 15; 85(2):145-52. PubMed ID: 25043275
    [Abstract] [Full Text] [Related]

  • 15. Ras antagonist farnesylthiosalicylic acid (FTS) reduces glomerular cellular proliferation and macrophage number in rat thy-1 nephritis.
    Clarke HC, Kocher HM, Khwaja A, Kloog Y, Cook HT, Hendry BM.
    J Am Soc Nephrol; 2003 Apr 15; 14(4):848-54. PubMed ID: 12660318
    [Abstract] [Full Text] [Related]

  • 16. RAS inhibitors: potential for cancer therapeutics.
    Kloog Y, Cox AD.
    Mol Med Today; 2000 Oct 15; 6(10):398-402. PubMed ID: 11006529
    [Abstract] [Full Text] [Related]

  • 17. The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.
    Reif S, Weis B, Aeed H, Gana-Weis M, Zaidel L, Avni Y, Romanelli RG, Pinzani M, Kloog Y, Bruck R.
    J Hepatol; 1999 Dec 15; 31(6):1053-61. PubMed ID: 10604579
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ras inhibition by FTS attenuates brain tumor growth in mice by direct antitumor activity and enhanced reactivity of cytotoxic lymphocytes.
    Aizman E, Mor A, Levy A, George J, Kloog Y.
    Oncotarget; 2012 Feb 15; 3(2):144-57. PubMed ID: 22323550
    [Abstract] [Full Text] [Related]

  • 20. Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice.
    Jansen B, Heere-Ress E, Schlagbauer-Wadl H, Halaschek-Wiener J, Waltering S, Moll I, Pehamberger H, Marciano D, Kloog Y, Wolff K.
    J Mol Med (Berl); 1999 Nov 15; 77(11):792-7. PubMed ID: 10619439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.